Boston Scientific Corporation recalls LGX Preconnect with TENACIO Pump without InhibiZone
The potential for devices to experience inflation and/or deflation performance issues or difficulties.
Drawn from openFDA device enforcement reports. Filter by severity, status, state, year, or manufacturer.
Showing 265–276 of 386 recalls
The potential for devices to experience inflation and/or deflation performance issues or difficulties.
The potential for devices to experience inflation and/or deflation performance issues or difficulties.
The potential for devices to experience inflation and/or deflation performance issues or difficulties.
The potential for devices to experience inflation and/or deflation performance issues or difficulties.
Vital sign monitoring instrument may trigger an error message during blood pressures measurements, Specifically, when the initial inflation pressure is set in the high-pressure range.
Device used for unilateral or bilateral occlusion of blood flow to the lower limbs has a potential manufacturing defect that may compromise the structural integrity of the device and device performance during use.
The bovine carotid arteries used to produce the impacted grafts from affected lots were sourced using raw material from a supplier that had not been reviewed and approved by the appropriate regulatory authority.
Potential for open header bag seals, compromising sterility.
Potential for open header bag seals, compromising sterility.
Baxter has identified that certain pumps have potentially been released with the grease applied to the cam and motor gears that will break down quickly.…
Insulin pumps manufactured with speakers from Revision A and B may malfunction ("Malfunction 16") which prevents audible alerts and causes the pumps to become inoperable and stop infusing insulin which could result in a…
The potential for unsterilized product within finished product labeled as sterile.